DE69931696D1 - Arzneimittel zur Verminderung der Effekte während oder nach der Menopause und Verfahren tur Behandlung under Verwendung derselben - Google Patents

Arzneimittel zur Verminderung der Effekte während oder nach der Menopause und Verfahren tur Behandlung under Verwendung derselben

Info

Publication number
DE69931696D1
DE69931696D1 DE69931696T DE69931696T DE69931696D1 DE 69931696 D1 DE69931696 D1 DE 69931696D1 DE 69931696 T DE69931696 T DE 69931696T DE 69931696 T DE69931696 T DE 69931696T DE 69931696 D1 DE69931696 D1 DE 69931696D1
Authority
DE
Germany
Prior art keywords
menopause
medicines
reducing
treatment
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69931696T
Other languages
English (en)
Other versions
DE69931696T2 (de
Inventor
Jack Auzerie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amistad Pharma S A S
Original Assignee
Amistad Pharma S A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amistad Pharma S A S filed Critical Amistad Pharma S A S
Publication of DE69931696D1 publication Critical patent/DE69931696D1/de
Application granted granted Critical
Publication of DE69931696T2 publication Critical patent/DE69931696T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69931696T 1998-06-02 1999-06-02 Arzneimittel zur Verminderung der Effekte während oder nach der Menopause und Verfahren zur Behandlung und Verwendung derselben Expired - Fee Related DE69931696T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9807051A FR2779062A1 (fr) 1998-06-02 1998-06-02 Preparation sous forme galenique simple visant a limiter les effets induits durant la menopause et posterieurement et traitement avec cette preparation
FR9807051 1998-06-02

Publications (2)

Publication Number Publication Date
DE69931696D1 true DE69931696D1 (de) 2006-07-20
DE69931696T2 DE69931696T2 (de) 2007-06-14

Family

ID=9527031

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69931696T Expired - Fee Related DE69931696T2 (de) 1998-06-02 1999-06-02 Arzneimittel zur Verminderung der Effekte während oder nach der Menopause und Verfahren zur Behandlung und Verwendung derselben

Country Status (7)

Country Link
EP (1) EP0968717B1 (de)
AT (1) ATE328597T1 (de)
DE (1) DE69931696T2 (de)
DK (1) DK0968717T3 (de)
ES (1) ES2267241T3 (de)
FR (1) FR2779062A1 (de)
PT (1) PT968717E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013464A1 (en) * 2004-07-27 2006-02-09 Amistad Pharma Sas Hormone replacement therapy comprising a combination of 17-beta-oestradiol and chlormadinone acetate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE4019670A1 (de) * 1990-06-22 1992-01-09 Erhard Dr Med Roemer Arzneimittel zur behandlung der wechseljahre der frau
SE9403389D0 (sv) * 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster

Also Published As

Publication number Publication date
ES2267241T3 (es) 2007-03-01
PT968717E (pt) 2006-09-29
EP0968717B1 (de) 2006-06-07
FR2779062A1 (fr) 1999-12-03
DE69931696T2 (de) 2007-06-14
EP0968717A1 (de) 2000-01-05
DK0968717T3 (da) 2006-08-14
ATE328597T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
AU7689791A (en) Drug-free method for treatment of alopecia
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE59505211D1 (de) Beatmungsgerät, insbesondere zur behandlung von ateminsuffizienzen, sowie verfahren zu dessen betrieb
DE3782917D1 (de) Verfahren zum herabsetzen des gehalts an rueckstaendigen aldehyden in implantierbaren bioprosthetischen geweben.
AU4969990A (en) Stabilized sterilizing or disinfecting halogen containing composition, method and apparatus
EP0604433A4 (de) Zusammensetzung und methode zur behandlung von krankheiten.
EP0528869A4 (de) Verfahren zum behandeln einer während einer angioplastie verletzten arterienwand.
PL299176A1 (en) Novel heterocyclic compounds, pharmaceutical agent, method of obtaining such novel heterocyclic compounds and initial compounds for obtaining them
GR3017996T3 (en) 17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
CA2071629A1 (en) Use of insulin sensitizing agents to treat hypertension
DE69124769D1 (de) Verfahren zur Herstellung von (1'R,3S)-3-(1'-hydroxy-ethyl)-Azetidin-2-on und deren Derivaten
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
DE69112340D1 (de) Verfahren zur Behandlung von Abgasen die Halogenverbindungen enthalten.
DE69509843D1 (de) Apparat zur Behandlung z.B. von Poststücken
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
KR0156686B1 (en) Pharmaceutical composition comprising aryl-substituted rhodanine derivatives
KR950700310A (ko) 헤테로트리사이클릭 유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물(heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them)
DE69209588D1 (de) Hochfeste, verschleissfeste Aluminiumlegierung und Verfahren zur Behandlung derselben
DE59300236D1 (de) Verfahren zur Herstellung von Tantal(v)-nitrid und dessen Verwendung.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
HU9301869D0 (en) New benzodiazepine derivatives, medical preparatives containing them and method for producing said compounds
DE59102745D1 (de) Verfahren une einrichtung zur behandlung von saatgut.
CA2282682A1 (en) Tazarotene and corticosteroid treatment for psoriasis
DE69931696D1 (de) Arzneimittel zur Verminderung der Effekte während oder nach der Menopause und Verfahren tur Behandlung under Verwendung derselben
ATE81499T1 (de) 2-acyloxypropylamin-derivate, verfahren zur herstellung und diese enthaltende arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee